Afatinib for the treatment of advanced non-small-cell lung cancer harboring an epidermal growth factor receptor exon 18 E709_T710delinsD mutation: a case report

Overview of attention for article published in Journal of Medical Case Reports, November 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 2 X users, with an upper bound of 3,792 followers.

Afatinib for the treatment of advanced non-small-cell lung cancer harboring an epidermal growth factor receptor exon 18 E709_T710delinsD mutation https://t.co/hfdmj9iKns https://t.co/4lqryccOyT

23 Dec 2021

Reply Repost Favourite

New article: Afatinib for the treatment of advanced non-small-cell lung cancer harboring an epidermal growth factor receptor exon 18 E709_T710delinsD mutation: a case report https://t.co/48fOQ94Mob #livercancer #oncology https://t.co/L7gtaNN6MH

23 Nov 2021

Reply Repost Favourite

New article: Afatinib for the treatment of advanced non-small-cell lung cancer harboring an epidermal growth factor receptor exon 18 E709_T710delinsD mutation: a case report https://t.co/DrAesUTbbA #lungcancer #oncology https://t.co/IE5OhNztrK

23 Nov 2021

Reply Repost Favourite

Afatinib for the treatment of advanced non-small-cell lung cancer harboring an epidermal growth factor receptor exon 18 E709_T710delinsD mutation: a case report https://t.co/evZ67YfBpl

23 Nov 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.